Question 1

What is multiple myeloma and how is it diagnosed?

Accepted Answer

Multiple myeloma is a cancer of plasma cells—a type of white blood cell in bone marrow—that overproduces abnormal proteins. Diagnosis typically involves blood tests (e.g., M-protein, free light chains), urine analysis, bone marrow biopsy, and imaging (such as skeletal survey or MRI) to detect bone lesions and organ damage.
Details from MedlinePlus (NIH.gov, 2024)

Question 2

What are common symptoms of multiple myeloma?

Accepted Answer

Symptoms often include bone pain (especially in the spine, chest, or hips), fatigue, recurrent infections, anemia, weight loss, kidney problems, and elevated calcium levels. Early stages may be symptom-free.
Details from Mayo Clinic (Symptoms & Causes, 2024)

Question 3

Can multiple myeloma go into remission?

Accepted Answer

Yes. Many patients achieve remission, meaning the disease becomes undetectable following treatment. However, regular monitoring is essential, as relapse can occur.
Details from NCBI (2022 update on diagnosis and management)

Question 4

Can multiple myeloma be cured?

Accepted Answer

While multiple myeloma is considered a chronic condition, some patients respond well to treatment for extended periods. Advances in therapies have helped many manage the disease long term, though a complete cure is currently rare.

Question 5

Where does multiple myeloma start and spread to?

Accepted Answer

Multiple myeloma starts in the bone marrow and can affect multiple bones. It does not usually spread like solid tumors, but it can impact organs such as the kidneys, spine, or, less commonly, soft tissues.

Question 6

How does multiple myeloma affect the kidneys and bones?

Accepted Answer

Cancerous plasma cells produce abnormal proteins that can damage kidneys. Bone involvement often results in fractures, osteoporosis, and elevated blood calcium, causing pain and weakness.
Details from Mayo Clinic (Diagnosis & Treatment, 2024)

Question 7

Can multiple myeloma cause neuropathy or blood clots?

Accepted Answer

Yes, some people with multiple myeloma may develop peripheral neuropathy (nerve pain or tingling), often as a result of treatments. The disease or its therapies can also increase the risk of blood clots in some cases.

Question 8

What is the prognosis for multiple myeloma?

Accepted Answer

Prognosis varies by age, stage at diagnosis, and response to treatment. While not usually curable, it is treatable, and many people live for years with the condition through ongoing care and advances in therapy.

Question 9

Are people with multiple myeloma immunocompromised?

Accepted Answer

Yes. Since the disease affects the immune system and its treatments may lower white blood cell counts, patients are generally considered immunocompromised and at higher risk for infections.

Question 10

Who is most likely to get multiple myeloma?

Accepted Answer

Multiple myeloma is more common in adults over age 60, and occurs more frequently in men than women. It also tends to affect African American individuals at a higher rate than other populations.

Multiple Myeloma Medications